I’m an active clinical researcher with publications across a number of internal medicine subspecialties, and most of my recent work is in melanoma outcomes. I also am interested in drug pricing and recently published a letter in JAMA Oncology on delays in oncology drug insurance formulary determination. In terms of prior biotech experience, I did business development work for Sarepta (Duchenne’s MD gene therapy company) in medical school, and during residency am consulting for Regeneron on clinical trials operations and innovative trial designs. I also do work on physician engagement and digital health for OneOncology, one of the country’s largest community based oncology practices. During med school, I took a leave to pursue an MPH at Johns Hopkins as a Sommer Scholar, focusing on drug safety.